WC500169468
WC500169468
WC500169468
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Health care<br />
professionals<br />
and patients<br />
PRAC<br />
members,<br />
PRAC<br />
alternates<br />
Country<br />
Outcome restriction following<br />
evaluation of e-DoI for the meeting:<br />
Topics on the current<br />
Committee Agenda<br />
for which restriction<br />
applies<br />
Product/substance<br />
Filip Babylon<br />
Full involvement<br />
Marco Greco<br />
Albert van der<br />
Zeijden<br />
Cannot act as Rapporteur or Peer reviewer<br />
for:<br />
Cannot act as Rapporteur or Peer Reviewer<br />
in relation to any medicinal product from<br />
the relevant companies for which his<br />
institution receives grants as listed in the<br />
published Declaration of Interest (2013-05-<br />
30)<br />
http://www.ema.europa.eu/docs/en_GB/do<br />
cument_library/contacts/avanderzeijden_DI<br />
.pdf<br />
infliximab<br />
Pharmacovigilance Risk Assessment Committee (PRAC)<br />
EMA/PRAC/324055/2014 Page 72/73
Change language